共 50 条
- [41] Molecular medicine, the medicare drug benefit, and the need for cost controlJOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (09) : 1442 - 1446Gillick, Muriel R.
- [43] Physicians' views of formularies: Implications for Medicare drug benefit designHEALTH AFFAIRS, 2004, 23 (01) : 218 - 226Landon, BEReschovsky, JDBlumenthal, D
- [44] The Medicare Part D drug benefit: Lessons from the experience with drug discount cardsAMERICAN JOURNAL OF GERIATRIC CARDIOLOGY, 2005, 14 (06): : 308 - 312Doering, PL
- [45] Senior citizens and the burden of prescription drug outlaysWhat lessons for the medicare prescription drug benefit?Applied Health Economics and Health Policy, 2004, 3 (4) : 217 - 227Panos KanavosMarin Gemmill
- [47] How the new Medicare drug benefit could affect vulnerable populationsHEALTH AFFAIRS, 2006, 25 (01) : 248 - 255Gellad, WFHuskamp, HAPhillips, KAHaas, JS
- [48] PBMs, formularies to play central roles in delivering Medicare drug benefitFORMULARY, 2004, 39 (01) : 51 - 52Wechsler, J
- [49] Implementing the Medicare drug benefit in a diverse inner-city communityAMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (02) : 193 - 199Stubbings, JoAnnDurley, Sandra F.Lin, Swu-JaneKliethermes, MarkAruru, Meghana DesaiEvangelista, ChristinaByun, Margaret
- [50] The Impact of the Medicare Part D Prescription Benefit on Generic Drug UseJournal of General Internal Medicine, 2008, 23 : 1673 - 1678James X. ZhangWesley YinShawn X. SunG. Caleb Alexander